MMCAP International Inc. SPC 13D and 13G filings for Cardiol Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-06 2:59 pm Sale | 2024-09-30 | 13G | Cardiol Therapeutics Inc. CRDL | MMCAP International Inc. SPC | 2,395,625 3.340% | -2,157,675 (-47.39%) | Filing |
| 2024-02-13 1:01 pm Sale | 2023-12-31 | 13G | Cardiol Therapeutics Inc. CRDL | MMCAP International Inc. SPC | 4,553,300 6.830% | -376,800 (-7.64%) | Filing |
| 2023-02-14 11:52 am Purchase | 2022-12-31 | 13G | Cardiol Therapeutics Inc. CRDL | MMCAP International Inc. SPC | 4,930,100 7.550% | 130,100 (+2.71%) | Filing |
| 2022-02-07 4:38 pm Purchase | 2021-12-31 | 13G | Cardiol Therapeutics Inc. CRDL | MMCAP International Inc. SPC | 4,800,000 7.550% | 4,800,000 (New Position) | Filing |